Keyword Tag Sort by


Categories: Nonalcoholic Fatty Liver Disease NAFLD Insulin Resistance Type 2 Diabetes Liver Apolipoprotein C3 Apo C3 Genes

Yale Researchers Identify Genetic Variants Linked to Increased Risk of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

New Haven, Conn. — For the first time, Yale researchers have identified common genetic variants that predispose lean individuals to nonalcoholic fatty liver disease (NAFLD) and insulin resistance. NAFLD is now the most common chronic liver disease in the U.S. and insulin resistance is the major factor that leads to type 2 diabetes. Their study also explains the mechanism by which individuals develop these conditions, despite maintaining normal body weight. The research appears in the March 25, 2010 issue of the New England Journal of Medicine.

The Yale team studied 95 young, lean, healthy Asian-Indian men, a cohort which they have previously found to have a high prevalence of NAFLD, to investigate whether there is a genetic cause for their increased liver fat content and insulin resistance. More specifically, they investigated the possible relationship between two variants in the apolipoprotein C3 (Apo C3) gene with liver fat content and insulin resistance. The team was led by Gerald I. Shulman, M.D., Ph.D., F.A.C.P., a Howard Hughes Medical Institute Investigator and the George R. Cowgill Professor of Physiological Chemistry, Medicine and Cellular & Molecular Physiology at Yale.

They found that individuals with these Apo C3 gene variants had significantly higher plasma Apo C3 concentrations associated with increased plasma triglyceride concentrations, a factor in the development of NAFLD. Furthermore they found that these individuals had much lower ability to clear plasma triglyceride from the blood stream. More importantly, approximately 40% of the men with these ApoC3 gene variants had NAFLD, whereas none of the men without the gene variants had NAFLD. In addition, those with NAFLD were markedly insulin resistant, a condition that is known to cause type 2 diabetes. Shulman’s team then went on to validate these findings in another group of 163 men of mixed ethnicity.

“Nonalcoholic fatty liver disease, insulin resistance, type 2 diabetes, and all of their associated conditions — such as cardiovascular disease, blindness, and kidney failure — are reaching epidemic proportions in this country, yet the genetic and molecular basis for these diseases remains poorly understood. In fact, type 2 diabetes has often been referred to as the ‘geneticist’s nightmare,’” Shulman says. “These studies demonstrate that the candidate gene approach for insulin resistance can work if it is approached from the underlying mechanism of lipid-induced causes.”

Interestingly, when the men with the ApoC3 gene variants underwent a modest weight loss, both NAFLD and insulin resistance improved, which Shulman says demonstrates important gene-environment interactions. “Taken together, I believe these Apo C3 gene variants lower the weight threshold for the development of NAFLD, insulin resistance and type 2 diabetes. Virtually everyone will develop NAFLD and insulin resistance if they become obese. But even at normal weight, individuals carrying these Apo C3 gene variants may develop NAFLD, insulin resistance and type 2 diabetes.”

Given the key role that NAFLD and insulin resistance play in the development of type 2 diabetes, Shulman and his team of researchers hope their finding of a genetic component for an increased susceptibility for NAFLD and insulin resistance will lead to new diagnostic tools to identify, and novel therapies to treat, individuals prone to develop these conditions.

Co-authors include Kitt Falk Petersen, Sylvie Dufour, Ali Hariri, Carol Nelson-Williams, Jia Nee Foo, Xian-Man Zhang, James Dziura and Richard Lifton of Yale School of Medicine.

The study was funded through grants from the Howard Hughes Medical Institute, the United States Public Health Service, the American Diabetes Association and Yale’s Clinical and Translational Science Award.

Contact: Helen Dodson, Tel: 203-436-3984

Source: Yale University

Related News:

Genetic mutations warn of skin cancer risk 1 April 2014, 05:59
New high-risk cancer causing mutation identified for melanoma developmentResearchers have...

Stem cells could set up future transplant therapies 30 October 2013, 05:22
New method for developing stem cells enables production of liver and pancreatic cells in...

Posttraumatic Stress Disorder Associated with Type 2 Diabetes 16 May 2013, 04:47
Neuherberg, Germany, May 16, 2013. The presence of posttraumatic stress disorder is...

Estrogen Fuels Autoimmune Liver Damage 30 April 2013, 08:14
Johns Hopkins research in mice unravels mystery behind sex disparities in drug-induced...

Why Does Smallpox Vaccine Shield Some, Not Others? It's in the... 22 April 2013, 08:07
ROCHESTER, Minn. — How well people are protected by the smallpox vaccine depends on more than...

Parkin protects from neuronal cell death 4 March 2013, 03:25
LMU researchers identify a novel signal transduction pathway, which activates the parkin gene...

Two new genes linked to amyotrophic lateral sclerosis (ALS) and... 4 March 2013, 03:18
St. Jude Children’s Research Hospital ties mutations in two genes to the death of motor...

Sitting less and moving about more could be more important than... 28 February 2013, 05:46
Prescribing less sedentary time, rather than more exercise, could be more important for patients...

Bowel cancers reshuffle their genetic pack to cheat treatment 27 February 2013, 03:30
Bowel cancer cells missing one of three genes can rapidly reshuffle their genetic ‘pack of...

Study reveals molecular networks of mental health disorders 27 February 2013, 03:26
Early diagnosis and intervention for ADHD, autism and schizophrenia could be made possible after...